CEimpact Podcast

What happens when pharmacy law and patient care don’t align? As a pharmacist during the COVID-19 pandemic, you are dealing with balancing legal liability and vaccine administration daily through ever-changing rules and regulations. This week’s episode shares hypothetical patient cases that David Brushwood, pharmacist attorney, and Jake Galdo, clinical pharmacist review. Together, they'll addr...

Repost Episode: Cognitive biases are pervasive and particularly troublesome in medicine. And guess what...we are all susceptible to cognitive biases! However, it is possible to learn to identify our biases and mitigate them. The decisions clinicians make in medicine can significantly impact an individual's life, morbidity, and mortality. And precepting is the perfect time to help students lea...

Pseudogout, or Calcium Pyrophosphate Deposition Disease (CPDD), is more common than you think – plus the treatment is even murkier. In this episode, we discuss its presentation, diagnosis, and treatment.  Continuing Education Credit Have a membership? Claim CPE Credit here! Claim CME Credit here! Need a membership? Join for CPE Credit here! Join for CME Credit here! References and resources: https...

For over 50 years, the standard has been that Staph aureus bacteremia and endovascular infections must be treated with a bactericidal antibiotic, like beta lactams or vancomycin. A new study suggests that bacteriostatic antibiotic, like clindamycin, could be used to treat MRSA bacteremia. Redeem your CPE or CME credit here ! References and resources: Guthridge I, Smith S, Law M, et al. Efficacy an...

Can a ‘report card' tame excessive prescriptions of antibiotics in outpatient settings? In this episode Dr. Wall with guest Josh Yost, MD, FACP will evaluate a paper that looked at using 'report cards' on antibiotic use and its impact on outpatient prescribing. Guest: W. John Yost, MD, FACP UnityPoint Health Earn CME or CPE credit here ! References and resources: Schwartz KL, Ivers...

Anti-mask and anti-vaccine fervor are causing an overload of the healthcare system and leading to increased mortality and morbidity. Three publications recently released, including a randomized controlled trial, evaluate community masking on COVID-19 spread. Guest Michael Hogue, PharmD, FAPhA, FNAP Dean, Loma Linda University Redeem your CPE or CME credit here ! References and resources: Abaluck J...

The recent ESCAPED study examines the treatment of Vaso-occlusive Crisis (VOC) in persons with Sickle Cell Disease (SCD). Many patients have difficulty receiving treatment due to a myriad of factors, including structural racism. Listen as Geoff examines if the ESCAPED study can shine a light on how to treat VOC in patients with SCD. Redeem your CPE or CME credit here! References and resources: Lan...

Recent studies have suggested that a short course of antibiotics, compared to longer durations, are just as efficacious for many common infections. The appropriate duration of urinary tract infections for men, by definition complicated, is uncertain due to the risk of developing secondary prostatitis. A new study evaluates 7 vs 14 days of antibiotic treatment of UTIs in men without fever. Redeem y...

The United States Preventative Services Task Force (USPSTF) announced new recommendations for diabetes screening. Approximately 34.5% of the US population has pre-diabetes – frequently attributed to the 75% of US adults with an overweight or obese body mass index. What makes 35 years old the new test screening age for diabetes compared to 40? Guest: John A Galdo, PharmD, MBA, BCPS, BCGP Course Con...

Proton Pump Inhibitors (PPIs), like all drugs, cause adverse drug events. Given the sheer number of patients prescribed, or using over-the-counter, PPIs, many practitioners may question continued use. Hear as Geoff examines a recent study from Ann Arbor which looked at the effects of a deprescribing program to step down from PPIs. Redeem your CPE or CME credit here by getting a GameChangers Subscr...

The Delta variant has made it clear the COVID pandemic is far from over. Recent studies have suggested that immunocompromised patients may have a reduced or no antibody response to the currently available COVID-19 vaccines. On August 13th, the CDC and FDA recommended that patients receive an additional vaccination. Hear Dr. Geoff Wall and guest, Dr. Nicole Alvey, on how immunocompromised patients...

A landmark paper published in 2002 set the standard for Targeted Temperature Management (TTM)  by having hospitals use TTM protocols to "cool" patients for a period of time after cardiac arrest to improve neurologic outcomes. On June 17th, 2021, the TTM-2 study was published and changed this standard. What is the future of the TTM modality in cardiac arrest patients? Redeem your CPE or C...

Do psychedelics treat mental illness? In this GameChanger episode host, Geoff Wall and guest, Sarah Grady, a psychiatric pharmacist, discuss a recent NEJM article comparing psilocybin (magic mushrooms) to escitalopram. Guest: Sarah Grady, PharmD Drake University Redeem your CPE or CME credit here with your GameChangers Subscription! We want your feedback! Share your feedback and experience with Ga...

The delta variant of COVID-19 has put the US in the precarious position of a fourth wave of the disease -- how efficacious are our vaccines against this variant? Also, are any new treatments for early COVID-19 being studied to help continue the fight? Find out more in this episode! Redeem your CPE or CME credit here ! We want your feedback! Share your feedback and experience with GameChangers! htt...

The first new treatment for Alzheimer's, aducanumab, was approved by the Food and Drug Administration on June 7, 2021. This approval did not come without controversy. Learn what the available data show for efficacy and safety and whether or not the current list price of $56,000 per year meets cost-effectiveness thresholds. Guest John A Galdo, PharmD, MBA, BCPS, BCGP Course Content and Develop...

A new study evaluates the cost-effectiveness of dapagliflozin in heart failure. Geoff and Jake continue the conversation from "Home Sweet Home (It's Where the Heart Is)" [Previous Episode] about the role of SGLT-2is in heart failure. This time the conversation is focused on the cost-effectiveness and QALYs. Is the price right for improved care? Redeem your CPE or CME credit here ! W...

New asthma guidelines came out in 2020 , yet the answer to triple or dual inhaler therapy wasn't explicitly answered. In this episode host, Geoff Wall and guest, Jake Galdo discuss the role of triple inhaler (ICS-LABA-LAMA) in the management of severe persistent and uncontrolled asthma. Redeem your CPE or CME credit with a GameChangers Subscription here ! We want your feedback! Share your fee...

The recently published ADAPTABLE study seeks to answer, definitively, a long held question: What is the correct dose of aspirin to improve outcomes in secondary prevention of cardiovascular disease? Also, more information about PCORnet, which is referenced in the article and during the episode, may be found here: https://pcornet.org/ Redeem your CPE or CME credit here ! We want your feedback! Shar...

Vaccines are the mainstay of care in the COVID-19 pandemic. However, patients may still become infected and need treatment options. Two studies have evaluated the role of inhaled budesonide for the early treatment of outpatient COVID-19 infections. Can budesonide hasten the resolution of symptoms or prevent hospitalizations? Redeem your CPE or CME credit here ! References and resources: Ramakrishn...

Diuretics, thiazide, and loop are critical medications for a number of disease states. Yet, they are often used inappropriately, either on the wrong dose or schedule or prescribed in patients who may not benefit from diuretics. This episode takes a look at diuretic pearls and how to get the most out of these medications. Resources: Ali S, Jung S, Nandkeolyar S, Stoletniy L, Sakr A, Verbrugge FH, H...

Longer antibiotics are associated with increased costs and adverse effects and increase the potential for bacterial resistance. A recent paper in the Lancet describes a study conducted in France comparing the outcomes of patients with community-acquired pneumonia (CAP) who are hospitalized but not critically ill with a short course of antibiotics (3 days) compared to standard treatment (8 days). T...

Replay of our Live Event Podcast on the Pharmacy Network. Host of GameChangers, Geoff Wall, PharmD, FCCP, BCPS, CGP and Jake Galdo, PharmD talked about season 1 recap, and season 2 new happenings! Season 2 officially launches early June! If you want to watch the live replay, check it out here . Follow CEimpact on Social Media: LinkedIn Instagram

It's the GameChangers' Birthday! This episode is a rapid review of a few subjects to celebrate the first year of GameChangers. From oral iron administration to the use of metronidazole with alcohol or serotonin syndrome, this episode has all the ingredients for a celebration! GameChangers' host, Geoff Wall, just released new music! Check out his latest EP here: https://open.spotify....

Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money. Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Dise...

More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate. This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Jans...